International Biotechnol... Share Discussion Threads

[rogerrail] 08/4/2014 10:03

way oversold now, NBI index was up 0.5% last night and most of IBT top 10 holdings either up or flat , only 9th largest holding Mylan down singficantly -4.4%, seems to be tracking BIOG not the NBI index, pity it was not tracking it on the way up !

%NBI
2,367.94 +11.34
0.48%
1.BIIB 294.19 +5.92
2.05%
2.GILD 72.23 +0.030
3.REGN 287.19 +1.85
0.65%
4.CELG 139.16 +1.78
1.30%
5.ALXN 145.66 +3.16
2.22%
6.AMGN 118.82 -0.290
-0.24%
7.ILMN 140.46 +1.89
1.36%
8.VRTX 66.40 +0.560
0.85%
9.MYL 48.40 -2.23
-4.40%
10 APTIV n/a

IBT 256.50 -14.00
-5.18%
BIOG 429.88 -18.62
-4.15

[maurillac] 07/4/2014 17:09

not all of them - maybe take a look at PEBI !
m

[philo124] 07/4/2014 16:18

Techs and Bios out of favour at the moment.

[rogerrail] 07/4/2014 16:15

Discount to NAV now widened to over 18%, this has to be an opportunity to add.

[davebowler] 28/3/2014 12:32

NAV is still higher than the peak price in FEB;

Date NAV Pence
Wednesday 26 Mar Ex Income 349.36

[pyemckay] 26/3/2014 14:00

general weakness in the sector will keep the wide discount for a while yet imo.

[trader2] 26/3/2014 13:52

Dave - Premium/discount has gone from about -5% in early Nov to about -25% now.

[davebowler] 26/3/2014 11:36

Net Asset Values

The Board of International Biotechnology Trust plc announces that the unaudited net asset value per share


Date NAV Pence
Tuesday 25 Mar Ex Income 355.66

[trader2] 26/3/2014 11:15

As I type ^NBI off 12% from recent high - IBT off 14%

[vulgaris] 26/3/2014 10:48

I think you'll find that falls track back to the row about pricing of Gilead's new hepatitis C drug and whether biotechs can make such prices (USD84000 per patient) stick or whether insurers and govts will decline to buy. Lots of biotech business models are predicated on such high prices.......

See

[trader2] 26/3/2014 09:51

Sure getting a good shake!

[snowydays] 24/3/2014 16:49

Yes, the NASDAQ biotech index is falling like a stone. Fears the bubble is bursting.

[incar] 24/3/2014 16:44

anyone know why this has dropped so much today?

[tokyo sexwhale] 24/3/2014 13:31

NAV 366 today

[melody9999] 24/3/2014 00:13

Discount has widened since 5th then. NAV 389p share price 330p
Now NAV 379p share price 315p

[davebowler] 06/3/2014 13:20

Date NAV Pence
------------------ ------------ -------
Wednesday 05 Mar Ex Income 389.76

[philo124] 27/2/2014 16:42

Holdings RNS.

[philo124] 26/2/2014 20:28

Bought another 1000 for SIPP.

[davebowler] 26/2/2014 12:05

Daily Funds
26 February 2014
2
Westhouse Securities
Trading ideas

In the UK, discounts on the lead biotech stocks con
tinue to widen, suggesting growing fears
that a bubble may be building. However, this does c
reate valuation opportunities, with
Biotech Growth Trust (BIOG.L, -6.0%)
and particularly,
International Biotechnology Trust
(IBT.L, -19.3%, Buy)
increasingly attractive at these levels. It is onl
y as recently as May 2013
that the market was willing to attribute a discount
of just 2% to IBT, since when the NAV has
added a further 29%. NAV performance remains strong
and the valuation here now fully
reflects growing valuation concerns in relation to
the broader biotech sector.

[warrensearle] 20/2/2014 18:27

Forget a dividend this is a growth fund of early stage companies that do not pay a dividend

[mozy123] 20/2/2014 16:58

Buy back or divi would both work. A shame they continue to do nothing about the issue

[pyemckay] 20/2/2014 16:21

A dividend would help imo.

[philo124] 20/2/2014 15:25

I had hoped that management would have got around to taking steps to buy back and cancel shares when the discount is above say 12.5%.

[philo124] 20/2/2014 15:25

I had hoped that management would have got around to taking steps to buy back and cancel shares when the discount is above say 12.5%.